AYURAX Trademark

Trademark Overview

On Thursday, August 29, 2019, a trademark application was filed for AYURAX with the United States Patent and Trademark Office. The USPTO has given the AYURAX trademark a serial number of 88597523. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, August 21, 2025. This trademark is owned by API2RX, LLC. The AYURAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, an analgesic for human consumption taken orally
ayurax

General Information

Serial Number88597523
Word MarkAYURAX
Filing DateThursday, August 29, 2019
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, August 21, 2025
Registration Number6049738
Registration DateTuesday, May 5, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, an analgesic for human consumption taken orally

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 14, 2019
Primary Code005
First Use Anywhere DateFriday, July 19, 2019
First Use In Commerce DateFriday, February 28, 2020

Trademark Owner History

Party NameAPI2RX, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMadisonville, LA 70447
Party NameAPI2RX, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMadisonville, LA 70447
Party NameAPI2RX, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMadisonville, LA 70447

Trademark Events

Event DateEvent Description
Monday, September 2, 2019NEW APPLICATION ENTERED
Thursday, December 5, 2019NON-FINAL ACTION E-MAILED
Thursday, December 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 3, 2019ASSIGNED TO EXAMINER
Thursday, December 5, 2019NON-FINAL ACTION WRITTEN
Sunday, December 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, December 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 1, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 11, 2019ASSIGNED TO LIE
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 11, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, March 11, 2020USE AMENDMENT FILED
Monday, March 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 30, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 5, 2020REGISTERED-PRINCIPAL REGISTER
Monday, May 5, 2025TEAS SECTION 8 RECEIVED
Thursday, August 21, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, August 21, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, August 19, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 2, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 5, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

ayurax consumption taken orally human analgesic preparations namely pharmaceutical